Messer G - Search Results

1

Use of high-dose immunoglobulins in dermatology.

Enk A, Fierlbeck G, French L, Hertl M, Messer G, Meurer M, Steinbrink K, Stingl G, Volc-Platzer B, Zillikens D. Enk A, et al. Among authors: messer g. J Dtsch Dermatol Ges. 2009 Sep;7(9):806-812. doi: 10.1111/j.1610-0387.2009.07118.x. J Dtsch Dermatol Ges. 2009. PMID: 19624804 English, German.

2

[The use of high dose intravenous immunoglobulins in dermatology].

Enk A, Hertl M, Messer G, Meurer M, Rentz E, Zillikens D. Enk A, et al. Among authors: messer g. J Dtsch Dermatol Ges. 2003 Mar;1(3):183-90. doi: 10.1046/j.1610-0387.2003.02028.x. J Dtsch Dermatol Ges. 2003. PMID: 16285493 German.

3

[Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group].

Mayrshofer F, Hertl M, Sinkgraven R, Sticherling M, Pfeiffer C, Zillikens D, Messer G, Rzany Für Die Deutschebsd-Studiengruppe B. Mayrshofer F, et al. Among authors: messer g. J Dtsch Dermatol Ges. 2005 Jun;3(6):431-5. doi: 10.1111/j.1610-0387.2005.05722.x. J Dtsch Dermatol Ges. 2005. PMID: 15892845 German.

4

High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgaris.

Messer G, Sizmann N, Feucht H, Meurer M. Messer G, et al. Br J Dermatol. 1995 Dec;133(6):1014-6. doi: 10.1111/j.1365-2133.1995.tb06952.x. Br J Dermatol. 1995. PMID: 8547028 No abstract available.

5

Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age.

Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, Prudlo C, Pawelczyk B, Messmer EM, Schuhmann M, Sinkgraven R, Büchner L, Büdinger L, Pfeiffer C, Sticherling M, Hertl M, Kaiser HW, Meurer M, Zillikens D, Messer G. Rzany B, et al. Among authors: messer g. Arch Dermatol. 2002 Jul;138(7):903-8. doi: 10.1001/archderm.138.7.903. Arch Dermatol. 2002. PMID: 12071817

6

[Diagnostic significance of autoantibodies in bullous dermatoses].

Messer G, Meurer M. Messer G, et al. Dtsch Med Wochenschr. 2001 Jan 26;126(4):79-82. doi: 10.1055/s-2001-10665. Dtsch Med Wochenschr. 2001. PMID: 11218565 Review. German. No abstract available.

7

Autoantibodies against desmocollins in European patients with pemphigus.

Müller R, Heber B, Hashimoto T, Messer G, Müllegger R, Niedermeier A, Hertl M. Müller R, et al. Among authors: messer g. Clin Exp Dermatol. 2009 Dec;34(8):898-903. doi: 10.1111/j.1365-2230.2009.03241.x. Epub 2009 May 18. Clin Exp Dermatol. 2009. PMID: 19456767

8

Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus.

Walchner M, Meurer M, Plewig G, Messer G. Walchner M, et al. Among authors: messer g. Int J Dermatol. 2000 May;39(5):383-8. doi: 10.1046/j.1365-4362.2000.00866.x. Int J Dermatol. 2000. PMID: 10849134

9

Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence.

Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Jung M, et al. Among authors: messer g. J Am Acad Dermatol. 1999 Aug;41(2 Pt 1):266-8. doi: 10.1016/s0190-9622(99)70061-7. J Am Acad Dermatol. 1999. PMID: 10426901

10

Treatment of pemphigus vulgaris with protein A immunoadsorption: case report of long-term history showing favorable outcome.

Frost N, Messer G, Fierlbeck G, Risler T, Lytton SD. Frost N, et al. Among authors: messer g. Ann N Y Acad Sci. 2005 Jun;1051:591-6. doi: 10.1196/annals.1361.103. Ann N Y Acad Sci. 2005. PMID: 16126999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters